Thiol levels, protein carbonylation and anaerobic sulfur metabolism in erythrocytes of peritoneal dialysis and predialysis patients

Nephrology

Volumn 15, Issue 8, 2010, Pages 755-761

  WŚodek, Przemysśaw ^a   Marcykiewicz, Bernadeta ^a   Iciek, Maśgorzata ^b   Suliga, Maśgorzata ^c   Smoleński, Olgierd ^a   Kowalczyk Pachel, Danuta ^b  

^a Ludwik Rydygier Speciality Hospital in Krakow   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Regional Blood Transfussion Center   (Poland)

Author keywords

peritoneal dialysis; protein carbonylation; renal failure; sulfane sulfur; thiols

Indexed keywords

3 MERCAPTOPYRUVATE SULFOTRANSFERASE; 3 MERCAPTOPYRUVIC ACID; CARBONYL DERIVATIVE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; THIOL DERIVATIVE; THIOSULFATE SULFURTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE METABOLISM; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION;

ADULT; ERYTHROCYTES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROTEIN CARBONYLATION; SULFHYDRYL COMPOUNDS; SULFUR; SULFUR COMPOUNDS;

EID: 78650674272     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01353.x     Document Type: Article

References (28)

1. Grune T, Sommerburg O, Siems WG,. Oxidative stress in anemia. Clin. Nephrol. 2000; 53: S18-22.
2. Włodek L,. Beneficial and harmful effects of thiols. Pol. J. Pharmacol. 2002; 54: 215-23.
3. Stȩpniewska J, Dolegowska B, Ciechanowski K, Kwiatkowski E, Millo B, Chlubek D,. Erythrocyte antioxidant defense system in patients with chronic renal failure according to the hemodialysis conditions. Arch. Med. Res. 2006; 37: 353-9.
4. Iciek M, Włodek L,. Biosynthesis and biological properties of compounds containing highly reactive reduced sulfane sulfur. Pol. J. Pharmacol. 2001; 53: 215-25.
5. Ogasawara Y, Soda S, Tanabe S,. Tissue and subcellular distribution of bound and acid-labile sulfur, and the enzymie capacity for sulfide production in the rat. Biol. Pharm. Bull. 1994; 17: 1535-42.
6. Włodek PJ, Iciek MB, Miłkowski A, Smoleński OB,. Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis. Clin. Chim. Acta. 2001; 304: 9-18.
7. Włodek L,. Rhodanese and 3-mercaptopyruvate sulphurtransferase activities in human red blood cells of different age groups. Folia Biol. (Kraków) 1981; 29: 279-86.
8. Hasuike Y, Nakanishi T, Moriguchi R, et al. Accumulation of cyanide and thiocyanate in haemodialysis patients. Nephrol. Dial. Transplant. 2004; 19: 1474-9.
9. Wood JL,. Sulfane sulfur. Methods Enzymol. 1987; 143: 25-9.
10. Sörbo B,. Rhodanese. Methods Enzymol. 1955; 2: 334-7.
11. Matsuo Y, Greenberg DM,. A crystalline enzyme that cleaves homoserine and cystathionine I. Isolation procedure and some physicochemical properties. J. Biol. Chem. 1958; 230: 545-60.
12. Valentine WN, Frankenfeld JK,. 3-Merkaptopyruvate sulfurtransferase [EC.2.8.1.2]: A simple assay adapted to human blood cells. Clin. Chim. Acta. 1974; 51: 205-10.
13. Ellman GL,. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959; 82: 70-7.
14. Sedlak J, Lindsay RH,. Estimation of total protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 1968; 25: 192-205.
15. Reznick AZ, Packer L,. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol. 1994; 233: 357-63.
16. Schmidtmann S, Baehr R, Precht K,. Free radical induced increased lysis of red blood cells after haemodialysis. Nephrol. Dial. Transplant. 1990; 5: 600-3.
17. Babior BM,. The respiratory burst of phagocytes. J. Clin. Invest. 1984; 73: 599-601.
18. Lucchi L, Bergamini S, Iannone A, et al. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Artif. Organs. 2005; 29: 67-72.
19. Ross EA, Koo LC, Moberly JB,. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am. J. Kidney Dis. 1997; 30: 489-94.
20. Durak J, Akuol O, Basesme E, et al. Reduced erythrocytes defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 1994; 66: 76-80.
21. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B,. Erythrocyte glutathione peroxidase activity, plasma malonyldialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin. Biochem. 2002; 35: 269-73.
22. Nagase S, Aoyagi K, Hiroyama A, et al. Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance. J. Amer. Soc. Nephrol. 1997; 8: 1157-63.
23. Salahudeen AK, Keavey PM, Hawkins T, Wilkinson R,. Is anaemia during continuous ambulatory peritoneal dialysis really better during hemodialysis? Lancet 1983; 2: 1046-9.
24. Schanuenstein E, Esterbauer H, Zollner H,. Aldehydes in Biological Systems: Their Natural Occurrence and Biological Activities. London: Pion Limited, 1977.
25. Miyata T, Sugiyama S, Saito A, Kurokawa K,. Reactive carbonyl compounds related uremic toxicity ('carbonyl stress'). Kidney Int. 2001; 59: S25-S31.
26. Miyata T, Kurokawa K, Ypersele de Strihou C,. Advanced glycation and lipoxidation end products: Role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J. Am. Soc. Nephrol. 2000; 11: 1744-52.
27. Buzaleh AM, Vázquez ES, Batlle AM,. Cyanide intoxication. II. The effects of systematic cyanide challenge on indicative toxicity parameters. Comp. Biochem. Physiol. 1990; 96: 177-80.
28. Galli F, Rovidati S, Benedetti S, et al. Overexpression of erythrocyte glutathione S-transferase in uremia and dialysis. Clin. Chem. 1999; 45: 1781-8.